Accepted for Publication: July 7, 2020.
Corresponding Author: Fiona P. Havers, MD, MHS, CDC COVID-19 Response Team, Centers for Disease Control and Prevention, 1600 Clifton Rd, MS H24-6, Atlanta, GA 30329 (firstname.lastname@example.org).
Published Online: July 21, 2020. doi:10.1001/jamainternmed.2020.4130
Author Contributions: Drs Havers and Lim had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Study concept and design: Havers, Reed, Lim, Hall, Fry, Owen, Blackmore, Blog, Lindquist, Turabelidze, Wiesman, Schiffer, Thornburg.
Acquisition, analysis, or interpretation of data: Havers, Reed, Lim, Montgomery, Klena, Cannon, Chiang, Gibbons, Krapiunaya, Morales-Betoulle, Roguski, Rasheed, Freeman, Lester, Mills, Carroll, Owen, Johnson, Semenova, Blog, Chai, Dunn, Hand, Jain, Lynfield, Pritchard, Sokol, Sosa, Watkins, Williams, Yendell, Schiffer, Thornburg.
Drafting of the manuscript: Havers, Lim, Klena, Fry, Thornburg.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: Havers, Lim, Gibbons, Roguski, Schiffer.
Obtained funding: Havers.
Administrative, technical, or material support: Havers, Montgomery, Klena, Cannon, Chiang, Morales-Betoulle, Mills, Carroll, Owen, Johnson, Semenova, Blackmore, Blog, Chai, Dunn, Jain, Lindquist, Pritchard, Sokol, Sosa, Turabelidze, Watkins, Wiesman, Williams, Schiffer, Thornburg.
Study supervision: Havers, Reed, Montgomery, Hall, Fry, Johnson, Blog, Pritchard, Schiffer, Thornburg.
Conflict of Interest Disclosures: Dr Wiesman reported receiving grants from US Department of Health and Human Services during the conduct of the study. No other disclosures were reported.
Funding/Support: This work was supported by the Centers for Disease Control and Prevention, Atlanta, Georgia.
Role of the Funder/Sponsor: The Centers for Disease Control and Prevention was involved in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, and approval of the manuscript; and decision to submit the manuscript for publication.
Group Information: The author members of the CDC COVID-19 Response Team are Drs Havers, Reed, Lim, Montgomery, Klena, Hall, Fry, Chiang, Morales-Betoulle, Rasheed, Freeman, Lester, Mills, Carroll, Owen, Johnson, Semenova, and Thornburg; Mses Cannon, Gibbons, Krapiunaya, and Roguski; and Mr Schiffer. The author members of the State Collaborator Group are Drs Blackmore, Blog, Chai, Dunn, Jain, Lindquist, Lynfield, Sosa, Turabelidze, Watkins, Wiesman, Williams, and Yendell; Mses Hand and Sokol; and Mr Pritchard.
Disclaimer: The findings and conclusions in the article are those of the authors and do not necessarily represent the views of the US Centers for Disease Control and Prevention.
Additional Contributions: We thank LabCorp and Quest for supplying specimens. From Quest: William A. Meyer III, PhD, Larry A. Hirsch, BS, Taylor Hwang, BS, and Janet M. Rochat, MS. From the New York City Department of Mental Health and Hygiene: Marcelle Layton, MD. From the Centers for Disease Control and Prevention Molecular Pathogenesis and Immunology Research Laboratory team: Bailey Alston, MS, Muyiwa Ategbole, MPH, Shanna Bolcen, MSPH, Darbi Boulay, BS, Peter Browning, BS, Li Cronin, MS, Ebenezer David, PhD, Rita Desai, BS, Monica Epperson, PhD, Yamini Gorantla, PhD, Lily Jia, MS, Han Li, PhD, Pete Maniatis, MS, Jeff Martin, BA, Kimberly Moss, BS, Kristina Ortiz, MS, Palak Patel, MS, So Hee Park, BS, Yunlong Qin, PhD, Evelene Steward-Clark, MS, Heather Tatum, BS, Andrew Vogan, MS, and Briana Zellner, PhD. We also thank Ian E. Fellows, PhD, of Fellows Statistics for input on statistical methodology. These individuals were not compensated directly by CDC for their participation in this specific study.
MA , Rudman
SL , Villarino
et al; CDC COVID-19 Response Team. Evidence for limited early spread of COVID-19 within the United States, January-February 2020. MMWR Morb Mortal Wkly Rep
. 2020;69(22):680-684. doi:10.15585/mmwr.mm6922e1PubMedGoogle ScholarCrossref
A , Hatfield
KM , Arons
et al; Public Health—Seattle & King County; CDC COVID-19 Investigation Team. Asymptomatic and presymptomatic SARS-CoV-2 infections in residents of a long-term care skilled nursing facility—King County, Washington, March 2020. MMWR Morb Mortal Wkly Rep
. 2020;69(13):377-381. doi:10.15585/mmwr.mm6913e1PubMedGoogle ScholarCrossref
FP , Reed
C , Lim
et al. Seroprevalence of antibodies to SARS-CoV-2 in six sites in the United States, March 23-May 3, 2020. medRxiv
. Preprint posted online June 26, 2020. doi:10.1101/2020.06.25.20140384
B , Lester
S , Mills
et al. Validation of a SARS-CoV-2 spike ELISA for use in contact investigations and serosurveillance. bioRxiv
. Preprint posted online April 25, 2020. doi:10.1101/2020.04.24.057323
J , Yuan
Q , Wang
et al. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin Infect Dis
. Published online March 28, 2020. doi:10.1093/cid/ciaa344PubMedGoogle Scholar
F , Wang
A , Liu
et al. Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications. medRxiv
. Preprint posted online April 20, 2020. doi:10.1101/2020.03.30.20047365
E , Mulaney
B , Sood
et al. COVID-19 antibody seroprevalence in Santa Clara County, California. medRxiv
. Preprint posted online April 30, 2020. doi:10.1101/2020.04.14.20062463
A , Pepper
G , Wener
et al. Performance characteristics of the Abbott Architect SARS-CoV-2 IgG assay and seroprevalence testing in Idaho. medRxiv
. Preprint posted online May 2, 2020. doi:10.1101/2020.04.27.20082362
D , Tan
J , Jiang
et al. Seroconversion of a city: longitudinal monitoring of SARS-CoV-2 seroprevalence in New York City. medRxiv
. Preprint posted online June 29, 2020. doi:10.1101/2020.06.28.20142190
L , Ren
L , Yang
et al. Profiling early humoral response to diagnose novel coronavirus disease (COVID-19). Clin Infect Dis
. Published online March 21, 2020. doi:10.1093/cid/ciaa310PubMedGoogle Scholar
KK , Tsang
OT , Leung
et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis
. 2020;20(5):565-574. doi:10.1016/S1473-3099(20)30196-1PubMedGoogle ScholarCrossref